Table 1 Comparison by duration of HFNC (less than 24 h versus greater than 24 h) for patients with ARF due to COVID-19 pneumonia who failed HFNC and were subsequently intubated
LESS THAN 24H | OVER 24H | TOTAL | P VALUES | |
|---|---|---|---|---|
TOTAL PATIENT VOLUME | 432 | 896 | 1328 | |
AVG. AGE (STD DEV) | 63 (14.9) | 65 (13) | 64 (13.68) | 0.0002 |
SEX (MALE), N (%) | 246 (56.9) | 544 (60.7) | 790 (59.5) | 0.19 |
COPD, N (%) | 131 (30.3) | 301 (33.6) | 432 (32.5) | 0.23 |
HF, N (%) | 113 (26.2) | 170 (19) | 283 (21.3) | 0.003 |
DM, N (%) | 133 (30.8) | 239 (26.7) | 372 (28) | 0.12 |
CKD, N (%) | 101 (23.4) | 211 (23.6) | 312 (23.5) | 0.95 |
HTN, N (%) | 300 (69.4) | 633 (70.7) | 933 (70.3) | 0.65 |
≥ 1 COMORBIDITY, N (%) | 372 (86.1) | 752 (83.9) | 1124 (84.6) | 0.30 |
TROPONIN (> 28NG/L), N (%) | 93 (21.5) | 161 (18) | 254 (19.1) | 0.12 |
CREATININE (> 1.5 MG/DL), N (%) | 85 (19.7) | 168 (18.8) | 253 (19.1) | 0.69 |
CRP (> 100 MG/L), N (%) | 132 (30.6) | 275 (30.7) | 407 (30.7) | 0.96 |
LYMPHOCYTES (< = 1 ΜL), N (%) | 243 (56.3) | 545 (60.8) | 788 (59.3) | 0.32 |
NT-PROBNP (> 88PG/ML), N (%) | 132 (30.6) | 269 (30) | 401 (30.2) | 0.84 |